Financial Summary (All financials)
| In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 4,916.0 | 5,234.0 | 5,903.0 | 5,518.0 | 5,075.0 | 5,351.0 | 4,945.0 | 4,552.0 |
| Revenue growth | -6.1% | -11.3% | 7.0% | 8.7% | -5.2% | 8.2% | 8.6% | -10.3% |
| Cost of goods sold | 582.0 | 835.0 | 1,219.0 | 1,139.0 | 1,037.0 | 1,142.0 | 1,056.0 | 1,098.0 |
| Gross profit | 4,334.0 | 4,399.0 | 4,684.0 | 4,379.0 | 4,038.0 | 4,209.0 | 3,889.0 | 3,454.0 |
| Gross margin | 88.2% | 84.0% | 79.3% | 79.4% | 79.6% | 78.7% | 78.6% | 75.9% |
| Selling, general and administrative | | | | 373.0 | 337.0 | 330.0 | 297.0 | 262.0 |
| General and administrative | 372.0 | 353.0 | 393.0 | | | | | |
| EBITA | 1,704.0 | 1,575.0 | 2,358.0 | 1,286.0 | 2,038.0 | 2,390.0 | 2,172.0 | 1,909.0 |
| EBITA margin | 34.7% | 30.1% | 39.9% | 23.3% | 40.2% | 44.7% | 43.9% | 41.9% |
| Amortization of intangibles | 74.0 | 79.0 | 74.0 | 65.0 | 81.0 | 70.0 | 58.0 | 54.0 |
| EBIT | 1,630.0 | 1,496.0 | 2,284.0 | 1,221.0 | 1,957.0 | 2,320.0 | 2,114.0 | 1,855.0 |
| EBIT margin | 33.2% | 28.6% | 38.7% | 22.1% | 38.6% | 43.4% | 42.8% | 40.8% |
| Pre-tax income | 1,236.0 | 621.0 | 1,665.0 | 1,578.0 | 1,415.0 | 1,744.0 | 1,506.0 | 1,271.0 |
| Income taxes | 216.0 | 161.0 | 382.0 | 419.0 | 370.0 | 487.0 | 383.0 | 352.0 |
| Tax rate | 17.5% | 25.9% | 22.9% | 26.6% | 26.1% | 27.9% | 25.4% | 27.7% |
| Earnings from continuing ops | 693.0 | 196.0 | 1,082.0 | 1,038.0 | 938.0 | 1,159.0 | 1,043.0 | 844.0 |
| Earnings from discontinued ops | | | | | 2.0 | 25.0 | 6.0 | 5.0 |
| Net income | 693.0 | 196.0 | 1,082.0 | 1,038.0 | 940.0 | 1,184.0 | 1,049.0 | 849.0 |
| Net margin | 14.1% | 3.7% | 18.3% | 18.8% | 18.5% | 22.1% | 21.2% | 18.7% |
| |
| Diluted EPS | $1.00 | $0.29 | $1.61 | $1.55 | $1.43 | $1.77 | $1.60 | $1.31 |
| Shares outstanding (diluted) | 696.0 | 672.0 | 672.0 | 671.0 | 656.0 | 653.0 | 650.0 | 643.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|